Novo Nordisk and Inversago Pharma have announced that Novo Nordisk has agreed to acquire Inversago for up to 1.075 billion dollars in cash.  (Source: © Martin Nordmark)
Business Strategy

Novo Nordisk to Takeover Inversago Pharma

Novo Nordisk has plans to acquire Inversago Pharma, a developer of CB1 receptor-based therapies for the potential treatment of obesity, diabetes and complications associated with metabolic disorders. The 1.075-billion-dollar acquisition includes Inversago Pharma’s lead development asset INV-202, an oral CB1 inverse agonist.

Read on
At a glance: Plant engineering projects from across the globe. (Source: Алина Бузунова - stock.adobe.com)
Plant Watch

Top 10 Engineering Projects of June 2023

PROCESS Worldwide brings to you the ‘Top 10 plant engineering projects of June 2023’ from all over the world. Right from Indorama Ventures developing the world’s first PET biorecycling plant to Sasa Polyester Sanayi establishing the world’s largest PDH unit in Turkey, find out all the projects making headlines here.

Read on